Innovation | Pharma Marketer

France’s Cytheris banks $15M for immunotherapy work

Monday, June 7th, 2010

Paris-based Cytheris has rounded up $15 million in its fourth venture round, with the money earmarked for new R&D work on

Posted in: Pharma News | 0 Comments »

Read the full story

Bayer to open biotech Innovation Center in Pfizer’s old SF digs

Tuesday, May 18th, 2010

To help in its hunt for new biotech collaborators active in hematology, oncology, cardiology, diagnostics and women’s health, Bayer HealthCare is planning to open a U.S. Innovation Center and relocate 65 of its researchers to Pfizer’s ( NYSE: PFE ) old offices in San Francisco. Bayer is taking half of Pfizer’s old space near UC San Francisco’s Mission Bay campus, according to the San Francisco Chronicle .

Posted in: Pharma News | 0 Comments »

Read the full story

$1B in cash grants available soon for small biotech

Friday, May 7th, 2010

by John Chase and Evan Ng, partners at Dorsey Whitney LLP The recently enacted healthcare reform legislation provides up to $1 billion in tax credits and cash grants for life sciences companies with 250 or fewer employees that have made or will make “qualified investments” in “qualifying therapeutic discovery projects” during 2009 and 2010. Credits and grants will be awarded through a competitive application process which is expected to commence on or before May 21, 2010. A “qualifying therapeutic discovery project” is a project which is designed to develop a product, process or therapy to diagnose, treat or prevent diseases and afflictions by (1) conducting pre-clinical activities, clinical trials, clinical studies and research protocols, or (2) developing technology or products designed to diagnose diseases and conditions, including molecular and companion drugs and diagnostics, or to further the delivery or administration of therapeutics.

Posted in: Pharma News | 0 Comments »

Read the full story

What’s Your Social Media Implementation Plan?

Friday, March 26th, 2010

Last week I posted ” Where’s Your Social Media Crisis Management Plan ,” which received some good responses from readers, including Sanofi-Aventis (S-A). Dennis Urbaniak, VP U.S.

Posted in: Digital Marketing, Social Media | 0 Comments »

Read the full story

What Has Sanofi-Aventis Learned from Its Facebook Experience?

Monday, March 22nd, 2010

Dennis Urbaniak, VP U.S. Diabetes and former VP of Innovation and New Customer Channels, Sanofi-Aventis, called what’s happening on the Wall of his company’s VOICES Facebook page a “key learning experience.” He made this comment in a call to me last week. To explain what he meant by that, I invited Mr.

Posted in: Social Media | 0 Comments »

Read the full story

What Would A Pharma Marketing Champ Do? 9 Imperatives for 2010

Friday, February 5th, 2010

This is the final post of a four-part series. Steve Jobs, Google, Good Life are three marketing champs. Read what Pharma marketing champs would do.

Posted in: DTC, Digital Marketing, Marketing Strategies, Mobile Marketing | 0 Comments »

Read the full story

2010 Outlook: 10 Ways to Win With Patients and Improve DTC Efforts

Tuesday, December 22nd, 2009

[Full article: 2010 Outlook: Doom and Gloom For DTC? 10 Points for Winning with Patients, published inDTC Perspectives, December 2009] Despite many gloomy predictions for DTC advertising and the pharma industry overall, there’s never been a better time for marketers to forward their brands and consumers’ lives with new thinking about what constitutes patient marketing in the [...]

Posted in: DTC, Digital Marketing, Social Media | 0 Comments »

Read the full story

Google Real Time Search and Crisis Communications

Saturday, December 12th, 2009

Everyone who works in crisis communications, or who may experience a crisis, should read this posting. The science of crisis communications got both faster, and more challenging with the advent of Twitter and the blogosphere.

Posted in: Regulatory | 0 Comments »

Read the full story